Whether designing new proteins or mapping DNA structure, these scientists aim to shed light on these fundamental questions through large-scale data collection, mathematical modeling, and quantitative analysis.

The Institute for Bioengineering of Catalonia (IBEC) is participating in the international SOLFEGE project, which aims to explore how different cell types coordinate with each other through soluble factors in the tumour microenvironment. This project has been made possible thanks to funding from the Human Frontier Science Program. SOLFEGE is a consortium led by the German Cancer Research Center (DKFZ), with IBEC and the Duke University, as partners.

 Dana-Farber Cancer Institute researchers have launched a study of a novel, homegrown blood test in hopes of identifying people who are at an elevated risk of lung cancer – despite never having used tobacco – and screen them for the disease. The team, led by principal investigator and thoracic oncologist Narjust Florez, MD, associate director of Dana-Farber’s Cancer Care Equity Program, designed the study in response to rising rates of lung cancer in younger people and prevalence in individuals of Asian or Hispanic/Latinx descent who have never used tobacco. 

A University of Michigan team identified herpes virus saimiri, which infects the T cells of squirrel monkeys, as a source of proteins that activate pathways in T cells that are needed to promote T cell survival.

‘Biomarkers’ may help to improve detection and treatment of gastrointestinal diseases such as gastric cancer, colorectal cancer, and inflammatory bowel disease.

The study conducted at the University of São Paulo evaluated data from 54 women who were newly diagnosed with early-stage disease. Accurately assessing a patient’s body composition is essential for monitoring metabolic changes related to breast cancer and identifying the need for earlier intervention, such as nutritional support and physical exercise.